However, no FDA-approved medications currently exist to treat both alcohol and nicotine dependence
This means food stays in your stomach longer, which makes you feel full for a longer time
The trial, funded by Novo Nordisk, the manufacturer of Wegovy (semaglutide), found the drug improved liver inflammation, scarring (fibrosis), and sometimes both in people with metabolic dysfunction-associated steatohepatitis (MASH)
That could be especially meaningful because NIAAA notes that only three medications are currently FDA-approved to treat alcohol use disorder
The dual action of tirzepatide, targeting both GLP-1 and GIP receptors, makes it a powerful option for weight management in individuals with significant weight challenges and associated health issues